$Novo-Nordisk A/S(NVO)$ I've been eyeing Novo Nordisk ($NVO) recently, and I'm intrigued by its position in the pharmaceutical sector, especially given its focus on diabetes and obesity treatments. As we all know, these are significant healthcare issues that aren't going away anytime soon.
Novo Nordisk has a long history of stable growth and has shown resilience during economic downturns. However, competition is fierce in the pharma sector, and it's not uncommon for market leaders to lose their position swiftly.
NVO has a history of providing decent dividends. Do you think this is sustainable in the long term?
Image
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
